| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | EP1202746A1 Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202705A2 Composition for restoring defects in calcified tissues |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases |
| 05/08/2002 | EP0839052B1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 05/08/2002 | EP0807110B1 Enterokinetic benzamide |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | DE10053813A1 Neue Verwendung von Sulfonamiden New use of sulfonamides |
| 05/08/2002 | DE10053384A1 Pharmazeutische Zubereitung aus Mariendistel und Terpenen Pharmaceutical composition of milk thistle and terpenes |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348455A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348386A Prucalopride oral solution |
| 05/08/2002 | CN1348381A Treatment with small peptides to effect antifibrotic activity |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1347715A Hepatitis B recuperating medicine granule |
| 05/08/2002 | CN1347713A Anorexia treating oral liquid |
| 05/08/2002 | CN1347712A Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer radically |
| 05/08/2002 | CN1347708A Bagged kidney-invigorating Chinese herbal medicine tea and its prepn |
| 05/08/2002 | CN1347701A Seahorse powder capsule |
| 05/08/2002 | CN1084194C Process for preparing ultramicro infant medicine |
| 05/08/2002 | CN1084192C Chinese patent drug for treating chronic diarrhea and its preparing method |
| 05/08/2002 | CN1084185C Liquid spray for treating oral and throat disease |
| 05/07/2002 | US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 05/07/2002 | US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists |
| 05/07/2002 | US6384225 Intermediates in the preparation of substituted chroman derivatives |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384059 Crystalline form of omeprazole |
| 05/07/2002 | US6384048 Imidazonaphthyridines |
| 05/07/2002 | US6384031 Cyclobutene derivatives useful as antagonists of the motilin receptor |
| 05/07/2002 | US6384024 Bile salt conjugates |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383768 Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucleotidyl transferase activities encoded by hepatitis C virus (HCV) |
| 05/07/2002 | US6383529 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 05/07/2002 | US6383513 Compositions comprising cannabinoids |
| 05/07/2002 | US6383510 Suppository form comprising an acid-labile active compound |
| 05/07/2002 | US6383485 Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
| 05/07/2002 | CA2214884C Poly(hydroxy acid)/polymer conjugates for skin applications |
| 05/07/2002 | CA2145000C Compounds which are selective antagonists of the human nk3 receptor and their use as medicinal products and diagnostic tools |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034904A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034761A1 Pyranoside derivatives |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034749A1 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034699A2 Mammalian metabolites of a tachykinin receptor antagonist |
| 05/02/2002 | WO2002034300A1 Polymer based radionuclide containing particulate material |
| 05/02/2002 | WO2002034299A1 Inorganic low density radionuclide coated particles |
| 05/02/2002 | WO2002034298A1 Low density radionuclide-containing particulate material |
| 05/02/2002 | WO2002034279A1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 05/02/2002 | WO2002034277A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara |
| 05/02/2002 | WO2002034275A1 Pharmaceutical preparation comprised of milk-thistle and terpenes |
| 05/02/2002 | WO2002034256A1 Process for producing granular drug preparation containing branched amino acids |
| 05/02/2002 | WO2002034255A1 Granular drug preparations containing branched amino acids and process for producing the same |
| 05/02/2002 | WO2002034244A2 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer |
| 05/02/2002 | WO2002034243A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2002034242A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2002034221A1 Dental care compositions |
| 05/02/2002 | WO2002034204A2 Calcilytic compounds |
| 05/02/2002 | WO2001098473A3 Method for isolating and purifying a protein and resulting protein |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001092282A3 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/02/2002 | WO2001090121A3 Methods and compositions for treating hepatitis c virus |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001070733A3 Di-substituted iminoheterocyclic compounds |
| 05/02/2002 | WO2001062082A3 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001052829A3 Statin-type bone growth stimulators |
| 05/02/2002 | WO2001052667A3 Pet food composition for treating helicobacter species in pets |
| 05/02/2002 | WO2001049280A3 Weight promoting composition, method, and product |
| 05/02/2002 | WO2001044264A3 Novel stromelysin inhibitors |
| 05/02/2002 | WO2001042207A3 Novel methods for the treatment and prevention of ileus |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | US20020052693 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 05/02/2002 | US20020052513 Oxamide IMPDH inhibitors |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052508 Heterocyclic thioamide derivatives |
| 05/02/2002 | US20020052504 N-((2-cyclopropoxy-5-(1H-tetrazol-1-))phenyl)methyl-2-(4 -phenyl)piperidin-3-amine and derivatives; in particular as neurokinin-1 receptor antagonists; analgesics; migraines; antiinflammatory, anxiolytic, emetic agents; antidepressants |